XML 92 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents [1] $ 2,059 $ 5,308
Accounts receivable [1] 65 13
Inventory [1] 73
Loans receivable, net of provision for credit losses of $279 and zero [1] 279
Prepaid expenses and other current assets [1] 180 129
Total current assets [1] 2,656 5,450
Property and equipment, net [1] 2,870 975
Operating lease right-of-use assets [1] 1,051 1,273
Intangible assets, net [1] 12,076 15,180
Goodwill [1] 55,573 55,573
Other non-current assets [1] 129 60
Total assets [1] 74,355 78,511
Current liabilities    
Accounts payable [1] 1,462 872
Accrued expenses [1] 639 2,961
Financial liabilities, current, net of issuance costs 1,925  
Other current liabilities [1] 786 760
Total current liabilities [1] 4,812 4,593
Financial liabilities, net of issuance costs [1] 7,188
Warrant liability [1] 528
Operating lease liabilities [1] 840 1,078
Total liabilities [1] 5,652 13,387
Contingencies (see Note 9) [1]
Stockholders’ equity    
Preferred stock, $0.0001 par value, 1,550 shares Series A Preferred authorized; 1,490 and 1,500 shares issued and outstanding as of December 31, 2023 and 2022, respectively; 3,080 shares of Series B Preferred Stock authorized, no shares issued and outstanding as of December 31, 2023 and 2022 [1]
Common stock, $0.0001 par value, 250,000 shares authorized; 77,451 and 55,963 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively [1] 8 6
Additional paid-in capital [1] 200,635 169,175
Accumulated deficit [1] (131,940) (104,057)
Total stockholders’ equity [1] 68,703 65,124
Total liabilities and stockholders’ equity [1] $ 74,355 $ 78,511
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.